| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.372 | 4.970 | 6.706 | 7.317 | 10.958 | 11.961 | 9.092 | 6.818 | 7.455 | 6.817 |
| Total Income - EUR | 5.372 | 4.970 | 6.870 | 7.317 | 10.994 | 11.961 | 9.092 | 6.818 | 7.455 | 6.817 |
| Total Expenses - EUR | 4.710 | 5.268 | 6.738 | 7.382 | 7.584 | 10.195 | 11.174 | 11.506 | 12.896 | 15.378 |
| Gross Profit/Loss - EUR | 662 | -298 | 132 | -65 | 3.410 | 1.767 | -2.082 | -4.688 | -5.441 | -8.561 |
| Net Profit/Loss - EUR | 501 | -397 | 65 | -138 | 3.300 | 1.654 | -2.162 | -4.756 | -5.516 | -8.629 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 |
Check the financial reports for the company - Prestosib-Ro Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 433 | 157 | 62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.349 | 1.361 | 1.106 | 1.932 | 3.776 | 5.695 | 3.384 | 732 | 714 | 606 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 587 | 327 | 606 | 944 | 0 | 1.746 | 846 | 585 | 505 | 571 |
| Cash | 1.762 | 1.033 | 499 | 988 | 3.776 | 3.949 | 2.538 | 147 | 208 | 35 |
| Shareholders Funds | 703 | -344 | 118 | -23 | 3.278 | 4.869 | 2.599 | -2.148 | -7.657 | -16.244 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.079 | 1.861 | 1.050 | 1.955 | 499 | 825 | 796 | 2.880 | 8.371 | 16.849 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8121 - 8121" | |||||||||
| CAEN Financial Year |
8121
|
|||||||||
Comments - Prestosib-Ro Srl